We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Disease Severity Predicted by Computer Model

By Biotechdaily staff writers
Posted on 25 Nov 2002
A study has shown that a computer model can be used to predict phenotypic behavior based on genetic information obtained from mapping of single nucleotide polymorphisms (SNPs). More...
The study was published in the November 2002 issue of Genome Research.

Single nucleotide polymorphisms are DNA sequence variations that occur when a single nucleotide (A,T,C,or G) in the genome sequence is changed. About two-thirds of all SNPs involve the replacement of cytosine (C) with thymine (T). SNPs occur every 100 to 300 bases along the human genome and are stable from an evolutionarily standpoint, making them easier to follow in population studies.

In the current study, researchers from the University of California, San Diego (UCSD, USA; www.ucsd.edu) used a computer model to relate specific genetic mutations to exact variations of a disease. They reviewed genetic information from patients who had an enzyme deficiency that caused hemolytic anemia. By inserting specific DNA sequences into a computer model for red blood cell metabolism, it was possible to predict accurately which mutations would result in chronic hemolytic anemia and which would cause a less severe version of the disease.

"The model is like the wiring diagram or design drawings for the cell,” explained senior author Dr. Bernhard Palsson, of the bioengineering department at UCSD. "It incorporates all the genes in the cell, the products of each, and the interwoven process of how those products interact to produce cellular functions. Once we have this computer model, it is in principle a fairly straightforward process to alter a specific DNA sequence, run a simulation on the program, and receive information back about how the defect impacts the cell's function.”

"Eventually, there could be a kind of databank of specific genetic mutations that cause precise disease variants,” said Dr. Palsson. "Some mutations will be severe, others benign. And every variation of a disease could be treated differently. This could be incredibly useful for drug development and will aid physicians in creating effective treatment plans for individuals.”



Related Links:
University of California, San Diego

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.